$FLCN SACRAMENTO, CA / ACCESSWIRE / April 17, 201
Post# of 33
(Total Views: 273)
Posted On: 04/17/2019 8:15:04 AM
$FLCN
SACRAMENTO, CA / ACCESSWIRE / April 17, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focusing on the marketing, sale, and distribution of CBD products and products derived from industrial hemp such as protein powder, hemp seeds and hemp oil has commented on the recent news that CVS began selling topical CBD products.
Universally known as CBD, Cannabidiol (the scientific name for CBD) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.
The 2018 Farm Bill legalized industrial hemp, removing this plant rich in CBD and nutritional supplements from the Controlled Substance Act and categorizing it as an agricultural commodity. This bill will allow states to regulate hemp farming while moving the industrialization of the hemp plant forward. As industrial hemp once again becomes one of America's most popular agricultural crops, the amount of CBD processed from the plant will grow exponentially. The hemp-CBD market is projected to grow from $600 million in 2018 to $22 billion by 2022.
Over the past week, CVS, one of North America's largest drug store chains began selling topical CBD products. In an interview with CNBC's Jim Cramer, CVS CEO Larry Merlo commented on CVS now selling CBD products, "We're going to be carrying them in 8 states. We're going to be carrying the topical products only. " Merlo added, "Anecdotally, we've heard from our customers that have used those products, it's helped for pain relief, arthritis and other ailments. We're going to walk slowly but we think this is something the customers are going to be looking for as part of the health offering."
William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, "We applaud CVS's entry into the CBD market. Several weeks ago, we announced that we filed a provisional patent application titled "CBD Formulations to Treat Acne". We are also working diligently behind the scenes to create CBD formulations for other skin conditions."
Delgado added, "It is critically important that our shareholders and investors understand we are one step ahead. The whole world is focusing on CBD topical formulations for pain. We believe it goes well beyond that and we will be announcing additional progress and CBD topical formulations over the next few weeks and months."
About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)
Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.
SACRAMENTO, CA / ACCESSWIRE / April 17, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focusing on the marketing, sale, and distribution of CBD products and products derived from industrial hemp such as protein powder, hemp seeds and hemp oil has commented on the recent news that CVS began selling topical CBD products.
Universally known as CBD, Cannabidiol (the scientific name for CBD) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. It is a major constituent of both plants, although the percentages of total composition can vary greatly from strain to strain. Unlike THC (the other prevalent cannabinoid), CBD is non-psychoactive while having the potential to possess a variety of therapeutic properties.
The 2018 Farm Bill legalized industrial hemp, removing this plant rich in CBD and nutritional supplements from the Controlled Substance Act and categorizing it as an agricultural commodity. This bill will allow states to regulate hemp farming while moving the industrialization of the hemp plant forward. As industrial hemp once again becomes one of America's most popular agricultural crops, the amount of CBD processed from the plant will grow exponentially. The hemp-CBD market is projected to grow from $600 million in 2018 to $22 billion by 2022.
Over the past week, CVS, one of North America's largest drug store chains began selling topical CBD products. In an interview with CNBC's Jim Cramer, CVS CEO Larry Merlo commented on CVS now selling CBD products, "We're going to be carrying them in 8 states. We're going to be carrying the topical products only. " Merlo added, "Anecdotally, we've heard from our customers that have used those products, it's helped for pain relief, arthritis and other ailments. We're going to walk slowly but we think this is something the customers are going to be looking for as part of the health offering."
William Delgado, Chairman and Chief Executive Officer of Falcon Technologies commented, "We applaud CVS's entry into the CBD market. Several weeks ago, we announced that we filed a provisional patent application titled "CBD Formulations to Treat Acne". We are also working diligently behind the scenes to create CBD formulations for other skin conditions."
Delgado added, "It is critically important that our shareholders and investors understand we are one step ahead. The whole world is focusing on CBD topical formulations for pain. We believe it goes well beyond that and we will be announcing additional progress and CBD topical formulations over the next few weeks and months."
About Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.)
Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) is a nutraceutical company developing a range of CBD-based products. The company's mission is to employ best practice science to source, manufacture and package all of its CBD products from within the United States. The company performs farm site visits and manufacturing site visits and sources its products from only the highest quality hemp farms and processors in North America. The company also aims to launch a line of CBD products specially formulated for animals by the end of 2019.
(0)
(0)